Apax to sell Endo Pharmaceuticals for $1.2bn

Private equity firm Apax Partners will sell Endo Pharmaceuticals to Qualitest Pharmaceuticals for around $1.2 billion in cash, the companies announced. Qualitest is a portfolio company of Apax Partners. Endo Pharmaceuticals is a U.S.-based healthcare company that focuses on high-value branded products and specialty generics.

DealsNorth AmericaUSBriefs